Protalix BioTherapeutics, Inc. announced that its Board of Directors has appointed Moshe Manor as its new President and Chief Executive Officer. Mr. Manor will assume office on November 2, 2014, when Dr. Aviezer will retire. He brings extensive knowledge and vast senior experience, both in the generic and the innovative pharmaceutical world, from his years as Executive Vice President at Teva Pharmaceutical Industries.

Most recently, Manor served as President, Teva Asia & Pacific where he led the strategy and development of a high growth region for Teva.